missing translation for 'onlineSavingsMsg'
Learn More

Midostaurin, MedChemExpress

Product Code. 16486457
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 mg
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
1mg
50mg
5mg
5 product options available for selection
Product selection table with 5 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
16486457 5 mg 5mg
16474796 100 mg 100mg
16470979 1 mg 1mg
16443728 10 mg 10mg
16400117 50 mg 50mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 5 options available.
5 options
This item is not returnable. View return policy
Product Code. 16486457 Supplier Medchem Express Supplier No. HY10230

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Midostaurin (PKC412; CGP 41251) is an orally active, reversible multi-targeted protein kinase inhibitor. Midostaurin inhibits PKCα/β/γ, Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFRβ and VEGFR1/2 with IC50s ranging from 22-500 nM. Midostaurin also upregulates endothelial nitric oxide synthase (eNOS) gene expression. Midostaurin shows powerful anticancer effects.

Midostaurin (PKC412

Specifications

Chemical Name or Material Midostaurin
CAS 120685-11-2
Color White
Purity Grade Notes Research
Molecular Formula C35H30N4O4
Quantity 5 mg
Synonym PKC412 CGP 41251
Solubility Information DMSO : 50 mg/mL (87.62 mM; Need ultrasonic)
SMILES O=C(C1=CC=CC=C1)N(C)[C@H]2[C@@H](OC)[C@@]3(C)N(C4=C5C=CC=C4)C6=C5C7=C(C(NC7)=O)C8=C6N(C9=CC=CC=C98)[C@@](O3)([H])C2
Molecular Weight (g/mol) 570.64
Formula Weight 570.64
Grade Research
Physical Form Powder
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.